Hypertension, Vol 21, 674-679, Copyright © 1993 by American Heart Association
MA Takiyyuddin, L De Nicola, FB Gabbai, TQ Dinh, B Kennedy, MG Ziegler, EL Sabban, RJ Parmer and DT O'Connor
Chromogranins A and B are major soluble proteins in chromaffin granules.
Their adrenomedullary content is increased in the spontaneously (genetic)
hypertensive rat. Is augmented catecholamine vesicular storage of the
chromogranins a specific feature of genetic hypertension? To explore this
question, we measured chromogranin A immunoreactivity, using a novel,
synthetic peptide radioimmunoassay, in rat adrenal medullas 4-6 weeks after
induction of the two-kidney, one clip Goldblatt model of renovascular
hypertension and in unmanipulated control animals. We also measured
messenger RNAs of chromogranins A and B and dopamine beta-hydroxylase by
Northern blot. Immunoreactive adrenal chromogranin A was 3.3-fold higher (p
< 0.01) in clipped rat adrenals. Adrenal catecholamine concentrations
and phenylethanolamine-N- methyltransferase activity were also higher in
clipped rats. Adrenal dopamine beta-hydroxylase activity (both
membrane-bound and soluble forms) and corticosterone (glucocorticoid)
concentration did not significantly differ between the groups. Adrenal
medullary chromogranin A messenger RNA levels in clipped rats were 3.2-fold
higher (p = 0.029) than those in the control group, and chromogranin B
messenger RNA levels were 4.6-fold higher (p = 0.05). Dopamine
beta-hydroxylase messenger RNA levels were 2.9-fold higher (p = 0.038).
Thus, augmented synthesis and storage of adrenomedullary chromogranins A
and B, catecholamines, and their biosynthetic enzymes appear to be
characteristic of both acquired and genetic hypertension.
ARTICLES
Catecholamine secretory vesicles. Augmented chromogranins and amines in secondary hypertension
Department of Medicine, University of California, San Diego 92161.
This article has been cited by other articles:
![]() |
G. Wen, J. Wessel, W. Zhou, G. B. Ehret, F. Rao, M. Stridsberg, S. K. Mahata, P. M. Gent, M. Das, R. S. Cooper, et al. An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension Hum. Mol. Genet., July 15, 2007; 16(14): 1752 - 1764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mahata, M. Mahata, G. Wen, W. B. Wong, N. R. Mahapatra, B. A. Hamilton, and D. T. O'Connor The Catecholamine Release-Inhibitory "Catestatin" Fragment of Chromogranin A: Naturally Occurring Human Variants with Different Potencies for Multiple Chromaffin Cell Nicotinic Cholinergic Responses Mol. Pharmacol., November 1, 2004; 66(5): 1180 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Greenwood, P. E. Cadman, M. Stridsberg, S. Nguyen, L. Taupenot, N. J. Schork, and D. T. O'Connor Genome-wide linkage analysis of chromogranin B expression in the CEPH pedigrees: implications for exocytotic sympathochromaffin secretion in humans Physiol Genomics, June 17, 2004; 18(1): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ely, A. Caplea, G. Dunphy, H. Daneshvar, M. Turner, A. Milsted, and M. Takiyyuddin Spontaneously Hypertensive Rat Y Chromosome Increases Indexes of Sympathetic Nervous System Activity Hypertension, February 1, 1997; 29(2): 613 - 618. [Abstract] [Full Text] |
||||
![]() |
M. A. Takiyyuddin, R. J. Parmer, M. T. Kailasam, J. H. Cervenka, B. Kennedy, M. G. Ziegler, M.-C. Lin, J. Li, C. E. Grim, F. A. Wright, et al. Chromogranin A in Human Hypertension : Influence of Heredity Hypertension, July 1, 1995; 26(1): 213 - 220. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1993 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |